Anti-TNFSF2/TNFa Antibody (Golimumab)
Catalog No.
F1072
Anti-TNFSF2/TNFa Antibody (Golimumab)
Featured Products
Golimumab (CNTO-148) is a potent human IgG1 TNFα antagonist monoclonal antibody. Golimumab has anti-inflammatory activity and inhibits the production of IL-6 and IL-1β. Golimumab prevents inflammation and cartilage or bone destruction by targeting and neutralizing TNF. Golimumab has anti-cancer activity and induces apoptosis. Golimumab can be used in rheumatoid arthritis, Crohn's disease and cancer research.
145 kDa
Dry ice
476181-74-5
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
SCH 900259, Simponi
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P01375
Human, Gorilla
Unconjugated
Monoclonal
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
TNFSF2 / TNFa
Please avoid freeze-thaw cycles.